World Premiere: Diaccurate, The Biotech Created by Truffle Capital, Reveals the Mechanism of Immune Disablement in HIV Infection
PARIS--(BUSINESS WIRE)--Mar 4, 2020-- |!| Fort Madison
PARIS--(BUSINESS WIRE)--Mar 4, 2020-- |!| Fort Madison